Maha Rashtra Apex Corporation Publishes Rights Issue Allotment Advertisement in Newspapers
Maha Rashtra Apex Corporation Limited published newspaper advertisements on May 08, 2026 under Regulation 92(1) of SEBI ICDR Regulations, disclosing the basis of allotment for its rights issue of 1,40,91,896 equity shares at Rs. 10 each. The issue was oversubscribed at 504.12% of the issue size, with 2,251 valid applications considered for allotment. Post-allotment, the company's paid-up equity share capital has doubled from Rs. 14,09,18,960 to Rs. 28,18,37,920, with trading expected to commence on May 12, 2026.

*this image is generated using AI for illustrative purposes only.
Maha Rashtra Apex Corporation Limited has published newspaper advertisements pertaining to the basis of allotment for its rights issue of 1,40,91,896 equity shares, pursuant to Regulation 92(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations"). The advertisement was published on Friday, May 08, 2026 in Financial Express (English national daily), Jansatta (Hindi national daily), and Vishwavani (regional language daily published at the place of the company's registered office). The intimation was filed with BSE Limited and National Stock Exchange of India Limited on May 09, 2026 by Jamsheed Minoo Panday, Company Secretary and Compliance Officer.
Rights Issue Overview
The rights issue comprised 1,40,91,896 equity shares of face value Rs. 10 each, issued at par (Rs. 10 per share), aggregating up to Rs. 14,09,18,960. The issue was offered in the ratio of 1 (one) rights equity share for every 1 (one) fully paid-up equity share held by existing equity shareholders on the record date of Friday, March 20, 2026. The subscription window opened on Thursday, April 02, 2026 and closed on Thursday, April 30, 2026, with the last date for on-market renunciation of Rights Entitlements being Friday, April 24, 2026.
Subscription and Allotment Details
The rights issue received strong investor response, with the total valid applications amounting to 504.12% of the issue size. Out of 2,679 total applications for 7,17,78,111 equity shares received through the Application Supported by Blocked Amount ("ASBA") process, 428 applications for 7,37,562 equity shares were rejected due to technical reasons. The total number of valid applications stood at 2,251 for 7,10,40,549 rights equity shares. The basis of allotment was finalised on Monday, May 04, 2026 in consultation with the Registrar to the Issue and BSE, the Designated Stock Exchange.
The following table summarises the applications received and allotment made across investor categories:
| Category: | Applications (No.) | Applications (%) | Shares Applied (No.) | Shares Applied Value (Rs.) | Shares Applied (%) | Shares Allotted (No.) | Shares Allotted Value (Rs.) | Shares Allotted (%) |
|---|---|---|---|---|---|---|---|---|
| Eligible Equity Shareholders | 2183 | 81.48 | 70414148 | 704141480 | 98.10 | 13959833 | 139598330 | 99.06 |
| Renouncees | 94 | 3.50 | 1064971 | 10649710 | 1.48 | 132063 | 1320630 | 0.94 |
| Not an Eligible Shareholder | 402 | 15.00 | 298992 | 2989920 | 0.42 | 0 | 0 | 0 |
| Total | 2679 | 100 | 71778111 | 717781110 | 100 | 14091896 | 140918960 | 100 |
Basis of Allotment
The table below presents the category-wise breakdown of valid applications considered and shares allotted:
| Category: | Valid Applications Considered | Shares Allotted Against Rights Entitlements (A) | Shares Allotted Against Additional Shares Applied (B) | Total Shares Allotted (A+B) |
|---|---|---|---|---|
| Eligible Equity Shareholders | 2158 | 11001739 | 2958094 | 13959833 |
| Renouncees | 93 | 132063 | 0 | 132063 |
| Total | 2251 | 11133802 | 2958094 | 14091896 |
Capital Structure Changes
Consequent to the allotment, the paid-up equity share capital of the company has effectively doubled. The pre and post-issue share capital details are as follows:
| Particulars: | No. of Equity Shares | Amount (Rs.) |
|---|---|---|
| Paid-up Share Capital (Pre-Rights Issue) | 1,40,91,896 | 14,09,18,960 |
| Paid-up Share Capital (Post-Rights Issue) | 2,81,83,792 | 28,18,37,920 |
Post-Allotment Timeline
Key post-allotment milestones and their respective dates are outlined below:
| Milestone: | Date |
|---|---|
| Basis of Allotment Finalised | Monday, May 04, 2026 |
| ASBA Unblocking Instructions to SCSBs | Monday, May 04, 2026 |
| Listing Application Filed with BSE & NSE | Tuesday, May 05, 2026 |
| Listing Approval Received | Wednesday, May 06, 2026 |
| Allotment Advice / Demat Credit Completed | Thursday, May 07, 2026 |
| Newspaper Advertisement Published | Friday, May 08, 2026 |
| Expected Commencement of Trading | Tuesday, May 12, 2026 |
The rights equity shares allotted are expected to commence trading on BSE Limited and NSE Limited on or about Tuesday, May 12, 2026, under ISIN INE843B01013, the same as the existing equity shares. No physical shares were tendered in the rights issue. The allotment was approved by the Board of Directors at its meeting held on April 04, 2026, conducted in consultation with Purva Sharegistry India Limited as Registrar to the Issue.
Regulatory Compliance
The company has complied with the disclosure requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The newspaper publication was made pursuant to Regulation 92(1) of the SEBI ICDR Regulations. The Letter of Offer is available on the websites of BSE Limited, NSE Limited, Purva Sharegistry India Limited, and the company's official website at https://www.maharashtraapex.com/ .
Historical Stock Returns for Maha Rashtra Apex Corporation
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.45% | +4.23% | -1.95% | +4.66% | -21.72% | +2.77% |
How might the doubling of Maha Rashtra Apex Corporation's paid-up share capital impact its earnings per share and valuation multiples in upcoming quarterly results?
What are the company's intended deployment plans for the Rs. 14.09 crore raised through this rights issue, and how could capital utilization affect future revenue growth?
Given the 504% oversubscription, could Maha Rashtra Apex Corporation consider additional fundraising rounds, and what regulatory constraints under SEBI ICDR would apply to a subsequent offering?


































